Outcome of patients with large vessel occlusion in the anterior circulation and low NIHSS score
Autor: | Jan Gralla, Panagiotis Chaloulos-Iakovidis, Bastian Volbers, Tomas Dobrocky, Marwan El-Koussy, Pasquale Mordasini, Leonidas Panos, Johannes Kaesmacher, Marcel Arnold, Urs Fischer, Simon Jung, Mirjam Rachel Heldner, Heinrich Mattle |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Neurology Intracranial haemorrhage Arterial Occlusive Diseases Severity of Illness Index Unmet needs Tertiary Care Centers 03 medical and health sciences 0302 clinical medicine Fibrinolytic Agents Outcome Assessment Health Care Humans Medicine Prospective Studies 030212 general & internal medicine 610 Medicine & health Aged Retrospective Studies Neuroradiology Aged 80 and over Nihss score business.industry Endovascular Procedures Middle Aged Optimal management Surgery Cohort Female Cerebral Arterial Diseases Neurology (clinical) business 030217 neurology & neurosurgery Large vessel occlusion |
Zdroj: | Journal of Neurology. 267:1651-1662 |
ISSN: | 1432-1459 0340-5354 |
Popis: | Optimal management of patients with large vessel occlusion (LVO) and low NIHSS score is unknown, which was the aim to investigate in this study. This is a retrospective analysis of a prospective single tertiary care centre 14-year cohort of patients with LVO in the anterior circulation and NIHSS score ≤ 5 on admission. Outcome was analysed according to primary intended therapy. Among 185 patients (median age 67.4 years), 52.4% received primary conservative therapy (including 26.8% secondary reperfusion in case of secondary neurological deterioration), 12.4% IV thrombolysis (IVT) only and 35.1% primary endovascular therapy (EVT). 95 (51.4%) patients experienced neurological deterioration until 3 months. Primary-IVT-only and primary-EVT compared to conservative-therapy patients had better 3 months’ outcome (54.5% vs. 30.8%: adjustedOR 6.02; adjustedp = 0.004 for mRS 0–1 and 54.7% vs. 30.8%: adjustedOR 5.09; adjustedp = 0.002, respectively). Also mRS shift analysis favored primary-IVT-only and primary-EVT patients (adjustedOR 6.25; adjustedp = 0.001 and adjustedOR 3.14; adjustedp = 0.003). Outcome in primary-IVT-only vs. primary-EVT patients did not differ significantly. Patients who received secondary EVT because of neurological deterioration after primary-conservative-therapy had worse 3 months’ outcome than primary-EVT patients (20.8% vs. 30.8%: adjustedOR 0.24; adjustedp = 0.047 for mRS 0–1 and adjustedOR 0.31; adjustedp = 0.019 in mRS shift analysis). Survival and symptomatic intracranial haemorrhage did not differ amongst groups. Our data indicate that primary IVT and/or EVT may be better than primary conservative therapy in patients with LVO in the anterior circulation and low NIHSS score. Furthermore, primary EVT was better than secondary EVT in case of neurological deterioration. There is an unmet need for RCTs to find the optimal therapy for this patient group. |
Databáze: | OpenAIRE |
Externí odkaz: |